The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 4.12
Ask: 4.70
Change: 0.94 (27.09%)
Spread: 0.58 (14.078%)
Open: 3.64
High: 4.80
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licensing Agreement with XS Inc

25 Oct 2010 09:34

RNS Number : 9316U
Plant Health Care PLC
25 October 2010
 



25 October 2010 

 

Plant Health Care plc

("Plant Health Care" or "the Company")

 

Plant Health Care announces Licensing Agreement with XS, Inc for

Computer Automated Spatial Analysis (CASA) technology

Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture and landscape industries, announces that it has licensed USA and international rights for its Computer Automated Spatial Analysis (CASA) technology to XS, Inc. of North Carolina (USA). This license agreement is further to the CASA patent application announced by Plant Health Care in March, 2010.

CASA is a ground breaking technology that enables the statistically accurate verification of field trial data from multiple areas in the same field, even in the presence of significant variability factors such as soil type, drainage and elevation.

The ability to accurately assess the impact of prescriptive input applications to small areas within a larger field enables farmers to manage the areas under investigation with a higher degree of precision thereby achieving higher yields, lower costs, and increased profitability.

The spatial analysis technology streamlines the process of collecting, assembling, and analysing electronically collected, geo-referenced yield data in such a manner that it is now economically practical to spatially analyse yield data from practically any field from which geo-referenced data is obtained.

XS and Plant Health Care will work together to fully automate the CASA system and market it to a wide customer base which includes the major agrochemical and seed companies, distributors and grower organisations worldwide. The two companies will share in the revenues generated from the licensed use of the system. Plant Health Care anticipates that this program will start contributing to profits in less than three years and that, based on rates for other precision agricultural technologies, plus the applicability of the system to over 200 million acres in the USA alone, that earnings in the tens of millions per year are foreseeable with wide adoption of the technology.

 

John Brady CEO of Plant Health Care commented: "XS, Inc. is the right company to continue the development of this exciting new agricultural technology. With literally tens of thousands of electronic data points associated with each field, and potentially tens of millions of acres as candidates to benefit from CASA analysis, the ability to process and protect vast quantities of on-line data is paramount. XS is the agricultural industry leader in on-line seed and crop protection data collection and analysis, and we are confident in their ability to deliver CASA technology to the market place."

 

Bill Barton, Co-founder and Managing Director of XS, Inc. said: "A critical piece of the process will be the ability to manage vast amounts of data from thousands of farmers in a customer friendly manner, while delivering the yield analysis information in a way that's intuitive and understandable in its presentation, valuable and practical in its application, and timely in its delivery. We already do that for agricultural input suppliers, so extending the service of data collection, protection, and analysis to farmers is a natural extension of our business, and we look forward to making the PHC system work."

 

*** ends ***

 

 

For further information, please contact:

 

Plant Health Care plc

XS, Inc.

John Brady, Chief Executive Officer

Bill Barton, Managing Director

Tel: +1-603-525-3702

Tel: +1-919-379-3524

jabrady@planthealthcare.com

bbarton@xsinc.com

 

Evolution Securities

Tavistock Communications

Tim Worlledge / Tim Redfern

Jeremy Carey/Simon Compton

Tel: +44-20-7071-4300

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

 

 

Notes to editors:

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

 

About XS, Inc.: For more than a decade, XS, Inc. has been a leader in Software as a Service (SaaS), providing scalable and comprehensive tools to data-driven organizations. A leader in transaction data collection, analysis and online reporting, XS transforms existing data into powerful tools for improving efficiency, identifying opportunities, evaluating performance, optimizing marketing efforts and maximizing client relationships. Through state-of-the-art software, XS helps clients create and deliver strategic business solutions. Headquartered in North Carolina's Research Triangle Park, XS powers its suite of solutions to a variety of clients across the globe. (www.xsinc.com)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGGWWUUPUURA
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.